In this blog the FG team would like to highlight our latest Open Access review on “Recent advances in the diagnosis and management of amoebiasis” by Cooney et al. This comprehensive but highly readable article will take you from wherever you are on the ‘zero to hero’ spectrum of amoebiasis to an overnight expert. […]
Category: Uncategorized
#FG Blog- British Society of Gastroenterology minimum service standards and good practice statements for Endoscopic Retrograde Cholangiopancreatography (ERCP)
Mohsan Subhani1, Simon M Everett2 Affiliations 1School of Medicine University of Nottingham, United Kingdom 2Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, UK Endoscopic Retrograde Cholangiopancreatography (ERCP) is one of the highest-risk procedures routinely performed by endoscopists (1). It is one of the most complex endoscopic procedures, often reserved for more advanced therapeutic interventions rather than routine diagnosis. […]
Let’s talk about sex (and IBD)
Sexual dysfunction is common amongst inflammatory bowel disease (IBD) patients, particularly in the presence of active disease. The prevalence is very high, 45%–60% of women and 15%–25% of men1. Reflecting on my own practice, I do not routinely ask patients about how IBD may affect their sex life and vice versa. However, this aspect is […]
#FGblog – Eosinophilic oesophagitis: the past, present, and future.
Eosinophilic oesophagitis (EoE) is an allergic disease of the oesophagus characterised by an elevated eosinophil count on oesophageal biopsy. It classically presents with dysphagia in adults; symptoms in children can be more varied, including abdominal pain and vomiting as well as dysphagia [1]. It is a relative newcomer in the world of gastrointestinal disease, first […]
#FGBlog – making waves: water exchange vs hybrid approach in colonoscopy
Water-aided colonoscopy is rapidly becoming more widely adopted by lower gastrointestinal endoscopists, and has previously been shown to increase patient comfort, adenoma detection rate and bowel cleanliness, albeit potentially at the cost of increased insertion time [1]. Two main variations in technique exist. Water exchange (WE) involves only using water to distend the bowel and […]
#FGBlog: #FGBlog: How can we support patients with advanced chronic liver disease better in our units?
Deaths from advanced chronic liver disease are increasing over the past 50 years1. Regardless of what type of gastroenterologist you are, you can probably think of a case of a patient with advanced chronic liver disease who has died. You may even have reflected on whether the circumstances could have been different if only we […]
#FGBlog: 2023 in review: summary of the 2023 #FGCup
We have just come to the end of our annual (friendly) competition, the #FGCup. We are very lucky to have had eight fantastic papers be included in a tournament and we thank our editor-in chief, Professor Mark Beattie, in helping to choose these. We also thank all our authors and reviewers for which this would […]
#FGBlog: Measuring disability in IBD, and its predictive value in treatment decisions
The importance of Patient Reported Outcome Measures (PROMs) in inflammatory bowel disease (IBD) is now widely appreciated. Despite this, only relatively recently were PROMs routinely incorporated into clinical trials as outcomes. Current tools available include the IBD questionnaire (IBDQ) for measuring health-related quality of life (HRQoL) and IBD-control for measuring patients’ perspective of disease control. […]
#FGBlog: Dedicated Barrett’s oesophagus surveillance lists: the future for better dysplasia detection?
Getting surveillance for Barrett’s oesophagus (BO) right is critical for early detection and prevention of oesophageal adenocarcinoma. When identified early, Barrett’s can be treated effectively with minimally invasive endoscopic techniques. Despite clear national guidelines on when and how to perform surveillance for BO, adherence to these guidelines is variable. In the most recent edition of […]
#FGBlog: Satellite liver centres for chronic disease vs. hepatocellular carcinoma (HCC): where do we go from here?
The “hub and spoke” model of liver transplant care that is used in some UK regions has been a concept over the past 10 years as described by John O’Grady in 20131.This sounds like a great idea on paper: you can see a patient as the hepatologist with chronic liver disease in clinic in a […]